A key aim of serosurveillance during the COVID-19 pandemic has been to estimate the prevalence of prior infection, by correcting crude seroprevalence against estimated test performance for PCR-confirmed COVID-19. We show that poor generalisability of sensitivity estimates to some target populations may lead to substantial underestimation of case numbers.
Keywords: COVID-19; antibody; sensitivity; serology; surveillance.
© The Author(s) 2022. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: firstname.lastname@example.org.